By Staff Reports
(DGIwire) – For most adults, moderate alcohol use—no more than two drinks a day for men and one for women and older people—is relatively harmless, the American Psychological Association reports. But heavier drinking quickly gets risky. According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), problem drinking that becomes severe is given the medical diagnosis of Alcohol Use Disorder (AUD). About 17 million Americans, notes the NIAAA, suffer from some form of AUD. Here are five questions to ask about this serious condition:
“Many current therapies for AUD have limited efficacy and low levels of adherence,” says Roger Crystal, M.D., CEO of Opiant. “In contrast, opioid antagonists have an established record of safety and efficacy. We expect that OPNT002 will be highly differentiated by being used on an ‘as needed’ basis.”
Opiant is studying the use of opioid antagonists in various delivery forms, in particular using nasal sprays, for the treatment of addictions. The company has already developed NARCAN® Nasal Spray, a version of naloxone, which is being marketed by its partner and licensee, Adapt Pharma.
“In light of the ongoing need for improved treatment of AUD, we are looking forward to refining our clinical plan and advancing our program into additional clinical studies,” Dr. Crystal adds.